KRAS Lung Cancer Treatment & Monitoring with Dr Fawzi Abu Rous | Pt 2/3
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
KRAS Lung Cancer Treatment & Monitoring with Dr Fawzi Abu Rous | Pt 2/3
-
ナレーター：
-
著者：
In this episode, Dr. Fawzi Abu Rous provides a comprehensive overview of the treatment, monitoring, and progression of KRAS-driven lung cancer. The discussion covers the use of immunotherapy, targeted therapies, and the importance of clinical trials. Additionally, the role of monitoring and the emergence of new therapies are explored in detail.
Takeaways
- KRAS Treatment Overview
- Monitoring and Progression in KRAS-Positive Lung Cancer
Chapters
- 00:00 Treatment for KRAS-Driven Lung Cancer
- 05:49 Early Stage Treatment and Monitoring
- 15:37 Monitoring and Clinical Trials
This episode is proudly sponsored by Revolution Medicines.
About Young Lung Cancer Initiative (YLCI) The YLCI is a 501(c)(3) nonprofit dedicated to the young-onset community. We provide support, research, and advocacy to ensure that no young person faces a lung cancer diagnosis alone.
Disclaimer: This podcast is for informational purposes only and is not medical advice. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.